- Home
- GORV vs LGVN Comparison
GORV vs LGVN Comparison
Compare GORV & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- LGVN
- Stock Information
- Founded
- GORV 1976
- LGVN 2014
- Country
- GORV United States
- LGVN United States
- Employees
- GORV N/A
- LGVN N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- GORV Consumer Discretionary
- LGVN Health Care
- Exchange
- GORV Nasdaq
- LGVN Nasdaq
- Market Cap
- GORV 25.3M
- LGVN 23.4M
- IPO Year
- GORV 2015
- LGVN 2021
- Fundamental
- Price
- GORV $7.14
- LGVN $1.47
- Analyst Decision
- GORV Hold
- LGVN Strong Buy
- Analyst Count
- GORV 2
- LGVN 3
- Target Price
- GORV $2.00
- LGVN $8.67
- AVG Volume (30 Days)
- GORV 80.2K
- LGVN 715.2K
- Earning Date
- GORV 08-15-2025
- LGVN 08-13-2025
- Dividend Yield
- GORV N/A
- LGVN N/A
- EPS Growth
- GORV N/A
- LGVN N/A
- EPS
- GORV N/A
- LGVN N/A
- Revenue
- GORV $767,257,000.00
- LGVN $2,225,000.00
- Revenue This Year
- GORV $15.65
- LGVN N/A
- Revenue Next Year
- GORV $20.54
- LGVN $51.48
- P/E Ratio
- GORV N/A
- LGVN N/A
- Revenue Growth
- GORV N/A
- LGVN 127.50
- 52 Week Low
- GORV $3.95
- LGVN $1.14
- 52 Week High
- GORV $106.80
- LGVN $4.88
- Technical
- Relative Strength Index (RSI)
- GORV 51.39
- LGVN 57.16
- Support Level
- GORV $6.49
- LGVN $1.37
- Resistance Level
- GORV $8.01
- LGVN $1.40
- Average True Range (ATR)
- GORV 0.74
- LGVN 0.12
- MACD
- GORV 0.04
- LGVN 0.02
- Stochastic Oscillator
- GORV 61.32
- LGVN 47.70
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.